Science Explorer Interactive view Map
Company · Washington D.C. · United States

Joel Popkin and Company

jpcecon.comROR OpenAlex
Research works
22
▼ 85% vs 2013–17
Citations
396
18.3 per fractional work
Top-10% rate
42.4%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Joel Popkin and Company is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Joel Popkin and Company?

By fractional works in all years, weighted toward what it does more of than the world: Economic Growth, Neurological Disorders, Pathogenesis, Digital Epidemiology, Disease Surveillance, Hiccups, Human Capital and Long-Term Care.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 10 words, with their numbers
  1. Economic Growth2▲ 11×5 topics
  2. Neurological Disorders1▲ 7.9×3 topics
  3. Pathogenesis1▲ 8.9×3 topics
  4. Digital Epidemiology1▲ 266×1 topic
  5. Disease Surveillance1▲ 266×1 topic
  6. Hiccups1▲ 1039×1 topic
  7. Human Capital1▲ 34×2 topics
  8. Long-Term Care1▲ 69×2 topics
  9. Pharmacological Treatment1▲ 1039×1 topic
  10. Regional Development1▲ 18×2 topics

Which research topics does Joel Popkin and Company publish most on?

By volume in 2022–2025: Opioid Use Disorder Treatment, HIV, Drug Use, Sexual Risk, Pain Management and Opioid Use and Systemic Sclerosis and Related Diseases.

Opioid Use Disorder Trea…0Opioid Use Disorder Treatment: 0 fractional worksHIV, Drug Use, Sexual Risk0HIV, Drug Use, Sexual Risk: 0 fractional worksPain Management and Opio…0Pain Management and Opioid Use: 0 fractional worksSystemic Sclerosis and R…0Systemic Sclerosis and Related Diseases: 0 fractional worksSkin Diseases and Diabetes: 0 fractional worksDiabetic Foot Ulcer Assessment and Management: 0 fractional worksGlobal Maternal and Chil…0Global Maternal and Child Health: 0 fractional worksCardiac, Anesthesia and Surgical Outcomes: 0 fractional worksHealthcare Systems and Technology: 0 fractional worksGlobal Health and Surgery0Global Health and Surgery: 0 fractional works
Public Health, Environmental and Occupational HealthEpidemiologyAnesthesiology and Pain MedicinePathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
  2. 2 HIV, Drug Use, Sexual Risk Epidemiology 0 works
  3. 3 Pain Management and Opioid Use Anesthesiology and Pain Medicine 0 works
  4. 4 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
  5. 5 Skin Diseases and Diabetes Dermatology 0 works
  6. 6 Diabetic Foot Ulcer Assessment and Management Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 0 works
  8. 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Healthcare Systems and Technology Organizational Behavior and Human Resource Management 0 works
  10. 10 Global Health and Surgery Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.8%not open57.2%

World: 28% of research is openly available.

with international co-authors38.6%domestic only61.4%

World: 19% is written across borders.

How has Joel Popkin and Company's research output changed?

Output in 2018–2022 was 85% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Washington D.C.

All research institutions in Washington D.C.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.